J.-C. Roujeau
University of Paris
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by J.-C. Roujeau.
British Journal of Dermatology | 2007
Alexis Sidoroff; Ariane Dunant; Cécile Viboud; Sima Halevy; J.N. Bouwes Bavinck; Luigi Naldi; Maja Mockenhaupt; J-P. Fagot; J.-C. Roujeau
Background Acute generalized exanthematous pustulosis (AGEP) is a disease characterized by the rapid occurrence of many sterile, nonfollicular pustules usually arising on an oedematous erythema often accompanied by leucocytosis and fever. It is usually attributed to drugs.
British Journal of Dermatology | 2013
Sylvia H. Kardaun; Peggy Sekula; Laurence Valeyrie-Allanore; Yvonne Liss; Chia-Yu Chu; Daniel Creamer; Alexis Sidoroff; Luigi Naldi; Maja Mockenhaupt; J.-C. Roujeau
Cases of severe drug hypersensitivity, demonstrating a variable spectrum of cutaneous and systemic involvement, are reported under various names, especially drug reaction with eosinophilia and systemic symptoms (DRESS). Case definition and overlap with other severe cutaneous adverse reactions (SCAR) are debated.
British Journal of Dermatology | 2010
Laurence Valeyrie-Allanore; P. Wolkenstein; L. Brochard; Nicolas Ortonne; B. Maître; J. Revuz; Martine Bagot; J.-C. Roujeau
Background Stevens–Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are acute mucocutaneous reactions associated with poor prognosis. The treatment is mainly symptomatic, based on supportive care. Until now, several curative treatments have been proposed without evidence of effectiveness.
British Journal of Dermatology | 1997
C. Paul; P. Wolkenstein; C. Prost; F. Caux; G. Rostoker; M. Heller; Janine Wechsler; J. Revuz; J.-C. Roujeau
No information is available concerning the target antigen(s) involved in drug‐induced linear IgA disease. The purpose of this study was to define better drug‐induced linear IgA desease by studying its immunopathological, immunoultrastructural and immunochemical characteristics in three patients. In the first patient. IgA deposits were seen in the lamina lucida. In the second and the third patients. IgA deposits were seen on each side of the lamina densa. Immunoblotting of the first patients serum showed that IgA reacted with a protein of 230 kDa similar to the bullous pemphigoid‐associated antigen 1 (BPAG 1). The second patients serum did not react with specific bands. In the third patient IgA antibodies reacted with a protein of 97 kDa on epidermal extracts. Our findings suggest that, as in idiopathic forms, the target antigen is not unique in drug‐induced linear IgA disease. In some patients, drug‐induced linear IgA disease may represent an IgA class response to the BPAG 1.
British Journal of Dermatology | 2013
C. Hotz; Laurence Valeyrie-Allanore; C. Haddad; Sophie Bouvresse; Nicolas Ortonne; T.-A. Duong; S. Ingen-Housz-Oro; J.-C. Roujeau; P. Wolkenstein; Olivier Chosidow
Acute generalized exanthematous pustulosis (AGEP) is a severe cutaneous adverse reaction characterized by rash with sterile pustules, high fever and elevated circulating neutrophil counts.
Dermatology | 2009
P. Wolkenstein; J. Revuz; J.-C. Roujeau; G. Bonnelye; J.J. Grob; Sylvie Bastuji-Garin
Background: Risk factors for psoriasis have been identified. Objective: To precisely define these associated factors. Methods: A survey was conducted using a questionnaire on a representative sample of the French population. A case-control study was conducted. Cases were persons who declared having had psoriasis during the previous 12 months. For each case, 3 matched controls were selected. Cases and controls were compared using univariate and multivariate analyses. Results: The questionnaire was filled out and returned by 6,887 (68.9%) of 10,000 subjects aged 15 years and over; 356 cases were identified. In multivariate analysis, a higher body mass index, current and former smoking habits and β-blocker intake were independently associated with a higher risk of psoriasis; intake of statins was associated with a decreased risk (p < 0.05). Conclusions: We confirmed the association of overweight, smoking habits and β-blocker intake with psoriasis and reported a decreased risk associated with statin intake.
British Journal of Dermatology | 2013
J. Chanal; S. Ingen-Housz-Oro; Nicolas Ortonne; T.-A. Duong; M. Thomas; Laurence Valeyrie-Allanore; B. Lebrun-Vignes; C. André; J.-C. Roujeau; Olivier Chosidow; P. Wolkenstein
Linear IgA bullous dermatosis (LABD) is a rare autoimmune blistering skin disorder characterized by linear deposits of IgA along the dermoepidermal junction, visualized by direct immunofluorescence (DIF). It is usually spontaneous and drug induced.
British Journal of Dermatology | 2013
S. Lipowicz; Peggy Sekula; S. Ingen‐Housz‐Oro; Yvonne Liss; Bruno Sassolas; Ariane Dunant; J.-C. Roujeau; Maja Mockenhaupt
Background Generalized bullous fixed drug eruption (GBFDE) is a rare cutaneous adverse reaction to drugs, and may resemble Stevens–Johnson syndrome (SJS) or toxic epidermal necrolysis (TEN), but is usually considered less severe.
British Journal of Dermatology | 2000
N. Bénéton; P. Wolkenstein; Martine Bagot; Cosnes A; Janine Wechsler; J.-C. Roujeau; J. Revuz
Amicrobial pustulosis associated with autoimmune diseases is an eruption involving the cutaneous flexures and scalp. We report two young women with this disease, in whom pustulosis healed with zinc supplementation. We suggest that it may be relevant to measure plasma zinc level in patients with such a disease.
British Journal of Dermatology | 2015
N. Ortonne; Laurence Valeyrie-Allanore; Sylvie Bastuji-Garin; J. Wechsler; S. de Feraudy; T.-A. Duong; M.-H. Delfau-Larue; Olivier Chosidow; P. Wolkenstein; J.-C. Roujeau
The histopathological features of drug rash with eosinophilia and systemic symptoms (DRESS) syndrome remain poorly characterized.